Literature DB >> 26232424

USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.

Tieju Liu1, Baocun Sun2, Xiulan Zhao1, Yanlei Li3, Xueming Zhao3, Ying Liu1, Zhi Yao3, Qiang Gu1, Xueyi Dong3, Bing Shao3, Xian Lin3, Fang Liu3, Jindan An3.   

Abstract

Vasculogenic mimicry (VM), a newly defined pattern of tumor blood supply, describes the functional plasticity of aggressive cancer cells that form vascular networks. In our previous study, breast cancer stem cells (CSC) were shown to potentially participate in VM formation. In this study, breast CSCs presented centrosome amplification (CA) phenotype and ubiquitin-specific protease 44 (USP44) upregulation. USP44 expression contributed to the establishment of bipolar spindles in breast CSCs with supernumerary centrosomes by localizing at pole-associated centrosomes. The bipolar spindle patterns of breast CSCs with CA, including planar-like and apico-basal-like, functioned differently during the VM process of CSCs. Moreover, the ability of transendothelial migration in VM-forming cells was increased. In vivo experiment results showed that CSC xenografts presented linearly patterned programmed cell necrosis, which provided a spatial foundation for VM formation as well as angiogenesis. Breast CSCs further showed increased levels of IL6 and IL8. However, USP44 silencing induced spindle multipolarity, abated VM, reduced transendothelial migration, and consequently decreased IL6 and IL8 levels in breast CSCs. Finally, USP44(+) CSC subclones (ALDH1(+)/USP44(+)/IL6(+)/IL8(+)) were identified in breast cancer specimens through consecutive sections scanning. The subclones were related not only to CA, but also to VM. Statistical analysis suggested that USP44(+) CSC subclones could be used as an independent prognostic biomarker of poor clinical outcomes in patients with breast cancer. Collectively, the identification of USP44(+) CSC subclones may contribute to the prediction of VM formation and aggressive behavior. This study provides novel insights into the therapy for advanced breast cancer. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26232424     DOI: 10.1158/1535-7163.MCT-15-0114-T

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  20 in total

1.  USP44 Is an Integral Component of N-CoR that Contributes to Gene Repression by Deubiquitinating Histone H2B.

Authors:  Xianjiang Lan; Boyko S Atanassov; Wenqian Li; Ying Zhang; Laurence Florens; Ryan D Mohan; Paul J Galardy; Michael P Washburn; Jerry L Workman; Sharon Y R Dent
Journal:  Cell Rep       Date:  2016-11-22       Impact factor: 9.423

Review 2.  Centrosome amplification: a suspect in breast cancer and racial disparities.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Endocr Relat Cancer       Date:  2017-05-17       Impact factor: 5.678

3.  USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.

Authors:  Chong Yang; Shikai Zhu; Hongji Yang; Sisi Deng; Ping Fan; Mi Li; Xin Jin
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 4.  Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis.

Authors:  Qiujun Guo; Yuan Yuan; Zhichao Jin; Tao Xu; Yebo Gao; Huamin Wei; Conghuang Li; Wei Hou; Baojin Hua
Journal:  Biomed Res Int       Date:  2016-10-12       Impact factor: 3.411

5.  Vasculogenic mimicry in small cell lung cancer.

Authors:  Stuart C Williamson; Robert L Metcalf; Francesca Trapani; Sumitra Mohan; Jenny Antonello; Benjamin Abbott; Hui Sun Leong; Christopher P E Chester; Nicole Simms; Radoslaw Polanski; Daisuke Nonaka; Lynsey Priest; Alberto Fusi; Fredrika Carlsson; Anders Carlsson; Mary J C Hendrix; Richard E B Seftor; Elisabeth A Seftor; Dominic G Rothwell; Andrew Hughes; James Hicks; Crispin Miller; Peter Kuhn; Ged Brady; Kathryn L Simpson; Fiona H Blackhall; Caroline Dive
Journal:  Nat Commun       Date:  2016-11-09       Impact factor: 14.919

6.  Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer.

Authors:  Yanwei Shen; Jianfeng Quan; Mengying Wang; Shuting Li; Jiao Yang; Meng Lv; Zheling Chen; Lingxiao Zhang; Xiaoai Zhao; Jin Yang
Journal:  Oncotarget       Date:  2017-04-07

7.  RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.

Authors:  Ohad Tarcic; Roy Z Granit; Ioannis S Pateras; Hadas Masury; Bella Maly; Yaara Zwang; Yosef Yarden; Vassilis G Gorgoulis; Eli Pikarsky; Ittai Ben-Porath; Moshe Oren
Journal:  Cell Death Differ       Date:  2017-02-03       Impact factor: 15.828

8.  Filtered selection coupled with support vector machines generate a functionally relevant prediction model for colorectal cancer.

Authors:  Musa Nur Gabere; Mohamed Aly Hussein; Mohammad Azhar Aziz
Journal:  Onco Targets Ther       Date:  2016-06-01       Impact factor: 4.147

9.  Vascular Mimicry: The Next Big Glioblastoma Target.

Authors:  Ali S Arbab; Meenu Jain; B R Achyut
Journal:  Biochem Physiol       Date:  2015-08-31

10.  Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells.

Authors:  Ying Liu; Baocun Sun; Tieju Liu; Xiulan Zhao; Xudong Wang; Yanlei Li; Jie Meng; Qiang Gu; Fang Liu; Xueyi Dong; Peimei Liu; Ran Sun; Nan Zhao
Journal:  Onco Targets Ther       Date:  2016-06-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.